Bronchodilators and Sympathetic Nervous System Mechanisms

Introduction to Respiratory Pharmacology and Bronchodilators

• Context and Educational Resources:
  • Bronchodilators are presented as part of a broader study of respiratory therapy which includes:
    • Key chest x-ray terminology.
    • Key waveform analysis.
    • Identification of abnormal physiological findings.
  • Comprehensive review programs are available to support success in clinical classes, specifically focusing on:
    • The major classifications of pharmacology.
    • Pharmacological formulas.
    • Arterial Blood Gas ($ABG$) interpretation.
    • The $TMC$ (Therapist Multiple Choice) gatekeeper exam preparation through specialized boot camps.
    • The $CSE$ (Clinical Simulation Examination) preparation via specialized boot camps.

The Mechanism of the Effector Site

• Defining the Effector Site:
  • The "effector site" is the specific location within the body where a physiological change is intended to occur.
• Neurotransmitter Interaction:
  • The effectiveness of bronchodilators depends on the interaction between a neurotransmitter and a binding site at the effector site.
  • Understanding the specific system used to deliver these drugs is critical for clinical practice.

The Sympathetic Nervous System (SNS) and Adrenergic Receptors

• Primary Neurotransmitter:
  • The Sympathetic Nervous System releases norepinephrine ($\text{norepi}$), which is also known as adrenaline.
  • The goal of this neurotransmitter is to find and bind to specific receptors to trigger a response.
• The Three Primary Adrenergic Receptors:
  1. Beta 1 ($\beta_1$):
     • Location: Primarily found in the heart.
     • Function: Responsible for increasing cardiac effects (e.g., heart rate and contractility).
  2. Beta 2 ($\beta_2$):
     • Location: Primarily found in the lungs.
     • Function: Responsible for bronchodilation (the relaxation and opening of the bronchial airways).
  3. Alpha ($\alpha$):
     • Location: Systemic blood vessels.
     • Function: Responsible for vasoconstriction (the narrowing of systemic vessels).
     • Important Distinction: Alpha receptors are associated with systemic vasoconstriction, not bronchial constriction.

Classification and Terminology of Bronchodilators

• Agonist Definition:
  • An agonist is a drug or substance designed to look like a natural neurotransmitter (such as norepinephrine) and create the same effect at the receptor site.
• Beta 2 Agonist ($\beta_2$ Agonist):
  • A drug specifically engineered to mimic norepinephrine to target the $\beta_2$ receptors in the lungs.
• Sympathomimetic:
  • This term refers to the system being utilized. These drugs mimic the Sympathetic Nervous System.
  • Physiological outcomes of sympathomimetic drugs include:
    • Increased bronchodilation.
    • Increased cardiac performance.
    • Decreased mucus production (a desirable effect in respiratory care).
• Adrenergic:
  • This term signifies that the drug is structurally similar to adrenaline and produces identical effects when binding to receptors.
  • It identifies the neurotransmitter that the drug is designed to replicate.